SCHEMBL6480933

SCHEMBL6480933

Cc1ccccc1C=Cc1c2ccccc2c(C=Cc2ccccc2C)c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 5/20 0.48
▸ KDM4E B2RXH2 4/20 0.48
▸ APOBEC3A P31941 1/20 0.48
▸ APOBEC3G Q9HC16 1/20 0.48
▸ ALDH1A1 P00352 6/20 0.48
▸ TSHR P16473 3/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ PABPC1 P11940 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ BLM P54132 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6480931 1.00 RAB9A (0.48) RAB9AKDM4EAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL1035353 0.85 ALDH1A1 (0.62) RAB9AKDM4EAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL1589395 0.85 ALDH1A1 (0.62) RAB9AKDM4EAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL31668810 0.83 ALDH1A1 (0.59) RAB9AKDM4EAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL1767678 0.83 ALDH1A1 (0.59) RAB9AKDM4EAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL142259 0.83 ALDH1A1 (0.59) RAB9AKDM4EAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL6483174 0.81 CHAT (0.50) RAB9AKDM4EAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL6483171 0.81 CHAT (0.50) RAB9AKDM4EAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL9806261 0.78 CHAT (0.65) RAB9AKDM4EALDH1A1SMN1; SMN2NPC1
SCHEMBL9806267 0.78 CHAT (0.65) RAB9AKDM4EALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050096491-A1 Aromatic methylidene compound, methylstyryl compound for producing the same, production method therefor, and organic electroluminescent element MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) 2005-05-05 — — US disclosed
US-20030224206-A1 Aromatic methylidene compound, methylstyryl compound for producing the same, production method therefor, and organic electroluminescent element MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. 2003-12-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050096491-A1 Aromatic methylidene compound, methylstyryl compound for producing the same, production method therefor, and organic electroluminescent element OR51E2, CYP4F11, ACAD11 RAB9A 3751/4885KDM4E 909/4885APOBEC3A 4081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback